Search results
Alpine Immune Sciences Inc’s latest rating changes from various analysts – Knox Daily
Knox Daily· 1 day agoAlpine Immune Sciences Inc’s recently made public that its Director Topper James N unloaded Company’s shares for reported $1227.0 on Apr 25 ’24. In the ...
Alpine Environmental Welcomes new Partners in Ownership, Paving the Way for Long-Term Success
Digital Journal· 14 hours agoIn addition, the company is pleased to elect Theresa Hazelrigg, currently Alpine's General Manager, to the position of CEO. The new owners and leadership will position < ...
Vertex Pharmaceuticals Inc (VRTX) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...
GuruFocus.com via Yahoo Finance· 1 hour agoVertex Pharmaceuticals Inc has made significant progress in its pipeline, including the completion of regulatory submissions for the vanzacaftor triple combination for cystic ...
Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline
Zacks· 5 days agoFree Report) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing ...
Alpine Awards Xtreme Autosound the 2023 Customer Care Award
Mobile Electronics· 5 days agoAlps Alpine North America, Inc. (“Alpine”) awarded the 2023 Customer Care Award to Xtreme Autosound & Marine during the Alpine ...
Vertex Pharmaceuticals Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Expansions
GuruFocus.com via Yahoo Finance· 11 hours agoStrategic Acquisition: Announced the acquisition of Alpine Immune Sciences, enhancing the pipeline...
NHI Announces Second Quarter 2024 Dividend
Digital Journal· 12 hours agoVienna...
Bob Ross' unfinished 32nd season of 'The Joy of Painting' begins airing today
Daytona Beach News-Journal via Yahoo News· 4 days agoJune 14 – “Woodland Peach.” June 21 – “Alpine Meadow.” June 28 – “Galaxy Grandeur.” July 5 – “Silver...
Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug
Morningstar· 12 hours agoBy Paul Ziobro Vertex Pharmaceuticals posted double-digit sales growth in the first-quarter, topping Wall Street expectations, on continued growth of its drug that treats cystic fibrosis. The biotechnology company on Monday reported a profit
Merit Financial Group LLC Sells 1,690 Shares of BrightSpire Capital, Inc. (NYSE:BRSP)
ETF DAILY NEWS· 24 hours agoMerit Financial Group LLC cut its holdings in BrightSpire Capital, Inc. (NYSE:BRSP – Free Report) by 1.3% in the fourth quarter, according to the company in its most recent ...
